• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

临床输血与检验 ›› 2026, Vol. 28 ›› Issue (5): 828-836.DOI: 10.3969/j.issn.1671-2587.2026.05.022

• 综述 • 上一篇    下一篇

慢性肾脏病患者输血相关风险的系统认识与临床管理策略

吴玲, 甘新宇, 谭强, 任丽娜, 彭涛   

  1. 西部战区总医院,四川成都 610083
  • 收稿日期:2026-09-02 修回日期:2026-09-22 出版日期:2026-10-20 发布日期:2026-11-11
  • 通讯作者: 彭涛,主要从事输血治疗研究,(E-mail)tao_1226@126.com。
  • 作者简介:吴玲,主要从事输血治疗研究,(E-mail)1146925221@qq.com。

Transfusion-Related Risks in Patients with Chronic Kidney Disease: A Systematic Overview and Clinical Management Strategies

WU Ling, GAN Xinyu, TAN Qiang, REN Lina, PENG Tao   

  1. The General Hospital of Western Theater Command, Chengdu 610083
  • Received:2026-09-02 Revised:2026-09-22 Online:2026-10-20 Published:2026-11-11

摘要: 慢性肾脏病(CKD)患者因肾性贫血、凝血异常及围手术期需求,输血率显著高于一般人群,且风险呈多重叠加特征。现有证据显示,CKD为输血相关循环超负荷(TACO)的重要独立危险因素(OR=27,95%CI:5.4—143);输血相关急性肺损伤(TRALI)主动监测发生率因成分而异,其中红细胞输注发生率0.17/万单位、血小板为0.31/万单位、血浆为3.19/万单位;我国维持性血液透析(MHD)患者血红蛋白达标(110~130 g/L)率仅44.2%。本文系统阐述TACO、TRALI、红细胞同种免疫、铁过载、输血传播感染(TTI)及输血相关移植物抗宿主病(TA-GVHD)的风险特征与机制,提出限制性输血、成分选择、扩展配型分层、辐照与去白细胞等防控策略,并探讨促红细胞生成剂(ESA)、低氧诱导因子脯氨酰羟化酶抑制剂(HIF-PHI)及患者血液管理(PBM)在减少输血需求中的作用。本文旨在为输血医学科主导CKD输血决策与质控提供循证参考。

关键词: 慢性肾脏病, 输血相关风险, 输血相关循环超负荷, 同种免疫, 铁过载, 患者血液管理

Abstract: Patients with chronic kidney disease (CKD) have a significantly higher transfusion rate than the general population owing to renal anemia, coagulopathy and perioperative requirements, and their transfusion-related risks are characterized by multiple and overlapping risks. Current evidence indicates that CKD is an important independent risk factor for transfusion-associated circulatory overload (TACO) (OR=27, 95%CI: 5.4—143); that the incidence of transfusion-related acute lung injury (TRALI) under active surveillance varies with blood component, being 0.17, 0.31 and 3.19 per 10 000 units transfused for red blood cells, platelets and plasma, respectively; and that only 44.2% of patients on maintenance hemodialysis in China achieve the target hemoglobin level of 110~130 g/L. This review systematically elaborates the risk profiles and underlying mechanisms of TACO, TRALI, red blood cell alloimmunization, iron overload, transfusion-transmitted infections (TTIs) and transfusion-associated graft-versus-host disease (TA-GVHD), and proposes prevention and control strategies including restrictive transfusion, appropriate blood component selection, risk-stratified extended antigen matching, irradiation and leukoreduction. The roles of erythropoiesis-stimulating agents (ESAs), hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) and patient blood management (PBM) in reducing the need for transfusion are also discussed. This review aims to provide an evidence-based reference for transfusion medicine-led decision-making and quality control of transfusion in patients with CKD.

Key words: Chronic kidney disease, Transfusion-related risk, Transfusion-associated circulatory overload, Alloimmunization, Iron overload, Patient blood management

中图分类号: